Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

NCT04120701 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT04120701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04120701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Phase 3
Overall status
Recruiting
Start date
January 17, 2020
Completion date
March 31, 2032
Enrollment
1,980 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with resected stage ii colon cancer